|
Question on the Use of Composite Outcomes vs. All-Cause Mortality in Drug Trials
|
|
9
|
170
|
May 21, 2025
|
|
Progression in cancer trials
|
|
26
|
5783
|
June 25, 2024
|
|
A randomized trial of epinephrine in out-of-hospital cardiac arrest
|
|
13
|
9898
|
September 27, 2022
|
|
When exactly does `sustained clinical recovery' occur?
|
|
6
|
2384
|
June 13, 2022
|
|
Extensions of 'worst-rank' score methods with outcomes truncated by death
|
|
13
|
3589
|
September 2, 2021
|
|
Ordinal outcomes in survival analysis
|
|
3
|
4766
|
January 15, 2021
|
|
Deviation in primary endpoint definition
|
|
12
|
7467
|
July 26, 2019
|
|
Joint models for longitudinal and time-to-event data analysis applied to RCTs
|
|
7
|
8019
|
April 22, 2019
|
|
Cumulative toxicity endpoint opinion
|
|
3
|
4422
|
March 5, 2019
|
|
Question on modeling repeated outcomes among single patients
|
|
9
|
7574
|
November 7, 2018
|
|
Examining the 'penumbra theory' via NINDS reanalysis
|
|
6
|
7014
|
September 20, 2018
|